Paul Wassmann

Analytical Strategy and Science Lead
Novartis
Paul Wassmann
Paul is analytical technology and strategy lead for NBEs at the Characterization/ Formulation/ Bioinformatics unit (CFB). This role includes evaluation and coordination of implementation of appropriate innovative and strategic concepts in analytical space for challenging and completely new Biologics modalities with main focus on liabilities evaluation of Biologics molecules and their developability assessment. Paul's prior industry experience includes Project management for Biosimilar projects at Solvias AG, Switzerland, and Scientific role in Antibody Engineering and Analytics departments at Glenmark SA, Switzerland. He holds a doctorate in Structural Biology from Biozentrum Basel, Switzerland.

Sessions

No data was found

Other Speakers